Praxsyn Corporation
PXYN · OTC
12/31/2018 | 12/31/2017 | 12/31/2014 | 12/31/2013 | |
|---|---|---|---|---|
| Market Cap | $5 | $5 | $15 | $2 |
| - Cash | $0 | $0 | $1 | $0 |
| + Debt | $2 | $2 | $4 | $6 |
| Enterprise Value | $7 | $6 | $18 | $8 |
| Revenue | $0 | $1 | $67 | $7 |
| % Growth | -90.1% | -98.8% | 852.9% | – |
| Gross Profit | $0 | $0 | $63 | $6 |
| % Margin | 29.4% | 47.1% | 94.6% | 90.1% |
| EBITDA | -$0 | -$3 | $19 | $3 |
| % Margin | -170.8% | -352.1% | 28.8% | 45.4% |
| Net Income | -$1 | -$3 | -$12 | $0 |
| % Margin | -695.5% | -426.8% | -18.5% | 3.3% |
| EPS Diluted | -0.001 | -0.005 | -0.05 | 0.001 |
| % Growth | 83.3% | 90.4% | -3,946.2% | – |
| Operating Cash Flow | – | – | -$24 | -$2 |
| Capital Expenditures | – | – | -$0 | -$0 |
| Free Cash Flow | – | – | -$24 | -$2 |